The effect on non-specifically acting transfer factor component on acnitis type of lupus miliaris faciei
Pentti Gröhn, Kirsti Kuokkanen and Kai Krohn
A chromatographically purified component of human dialyzable transfer factor, which was shown previously to cause a non-specific stimulation of cell-medicated immunity, was used in treatment of a patient with the acnitis type of lupus miliaris faciei and a negative skin reaction to 100 TU of PPD. After the treatment, skin reaction was positive with 10 TU of PPD, but no change was seen in the blast transformation test to PPD. The skin eruption started to heal after 2 weeks’ therapy and disappeared completely in 3 months.